Drugmaker Pfizer says it's received the final regulatory approvals for its $15.23 billion purchase of the injectable drug and infusion device maker Hospira, and says the deal will close in early September.
The New York company said Monday regulators in the U.S. and Brazil cleared the deal. European Union regulators approved it earlier this month, as did antitrust agencies in Canada and Australia.
02:18 Report: Royals, Cubs close to trading Wade Davis for Jorge Soler10
20:05 Headphone deal of the day: Klipsch Reference On-Ear Premium headphone for $3012
11:32 Brexit: EU negotiator says 'time's short' for reaching deal13
09:13 Rouhani says Iran will not let Trump rip up nuclear deal14